BBOTVSGTBP• 7 Days (Normalized)
BBOT vs GTBP (BridgeBio Oncology Therapeutics Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 25 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-1.52%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
GTBP Performance $6.1
-11.47%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+9.95 pts
BBOT outperforming by 9.95 percentage points
BBOTGTBP
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | BBOT Price | BBOT Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -1.52% | $6.10 | -11.47% | +9.95% |
| Sep 30, 2026 | $4.10 | +3.80% | $- | - | |
| Sep 29, 2026 | $3.92 | -0.76% | $6.88 | -0.22% | -0.54% |
| Sep 28, 2026 | $3.81 | -3.54% | $6.80 | -1.31% | -2.23% |
| Sep 25, 2026 | $3.95 | +0.00% | $6.89 | +0.00% | +0.00% |